Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v3-FR Version v3-FR
Language French French
Date Updated 2021-08-19 2021-08-19
Drug Identification Number 02279800 02279800
Brand name SANDOZ RISPERIDONE SANDOZ RISPERIDONE
Common or Proper name SANDOZ RISPERIDONE SANDOZ RISPERIDONE
Company Name SANDOZ CANADA INCORPORATED SANDOZ CANADA INCORPORATED
Ingredients RISPERIDONE RISPERIDONE
Strength(s) 1.0MG 1.0MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL ORAL ORAL
Packaging size 60FCT UD CA 60FCT UD CA
ATC code N05AX N05AX
ATC description ANTIPSYCHOTICS ANTIPSYCHOTICS
Reason for discontinuation Other (Please describe in comments) Other (Please describe in comments)
Anticipated discontinuation date
Actual discontinuation date 2021-08-13 2021-08-13
Remaining supply date 2021-08-13 2021-08-13
Discontinuation status Discontinued Discontinued
Discontinuation decision reversal no no
Information on remaining supply
Company comments New packaging; transition to new format of bottle of 100 tablets New packaging; transition to new format of bottle of 100 tablets
Health Canada comments